Food News and Research

RSS

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer Inc. issued the following statement in response to today's discussion by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) regarding the use of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)in adults 50 years of age and older.

23 Feb 2012

Breast feeding information collected by WIC verified through telephonic survey

While medical professionals have long known breastfeeding positively impacts infant and maternal health, few effective tools are available to measure breastfeeding practices nationally. According to a new study, one preexisting government-funded program is a potential wealth of accurate data about the breastfeeding practices of low-income mothers. This study was published in a recent issue of the Journal of Human Lactation.

23 Feb 2012

Overall positive attitude towards concept of uniform CVD prevention guidelines across Europe

The next Joint European CVD Prevention Guidelines, scheduled for publication later this year at EuroPRevent 2012, will be shorter, tighter and supported by fewer references.

23 Feb 2012

FDA, pharmaceutical companies announce solution to cancer drug shortage

The U.S. Food and Drug Administration and several pharmaceutical companies said Tuesday they have reached agreements to alleviate shortages for the drugs methotrexate and Doxil. Methotrexate is used to treat children with a form of leukemia and others with tumors of the breast and lungs. Doxil is used to treat ovarian cancer and multiple myeloma.

23 Feb 2012

U-M Cardiovascular Center now offers Edwards aortic valve replacement

As the population ages, more Americans will be susceptible to aortic stenosis, but not all patients can tolerate surgery to treat it. Select U.S. hospitals are now performing minimally invasive procedures called transcatheter aortic valve replacement, or TAVR, to replace a patient's diseased aortic valve without heart bypass or open heart surgery.

From Medtronic 23 Feb 2012

New model to evaluate probiotic survival in the gut

Functional foods containing bacteria with beneficial health effects, or probiotics, have long been consumed in Northern Europe and are becoming increasingly popular elsewhere. To be of benefit, however, the bacteria have to survive in the very hostile environment of the digestive tract.

23 Feb 2012

GOP presidential hopefuls face off in two battleground states

Issues ranging from plans to cap or cut Medicaid spending to voting positions on the Medicare prescription drug program are among the policies being tossed about as candidates jockey for Tea Party votes and conservative credentials.

23 Feb 2012

Pediatricians should screen all children for vitamin D deficiency

As study after study shows the fundamental role vitamin D plays in disease and health, vitamin D deficiency — which often develops insidiously in childhood — should be on every parent's and pediatrician's radar, say physicians from the Johns Hopkins Children's Center.

23 Feb 2012

Micronutrients affect methylation, linked to changes in the immune system

The offspring of women who were given micronutrient supplements (minerals needed in small quantities, such as iron, iodine and vitamin A) before they became pregnant had gene modifications at birth as well as when they were tested at 9 months.

23 Feb 2012

Viewpoints: Real 'doc fix,' Saint Santorum and why Supreme Court TV is 'a bad idea'

In last week's flurry of budget deals, Congress patched together yet another temporary fix for a flawed formula used to calculate the fees paid to doctors by Medicare. It will hold payments flat for the next 10 months instead of cutting them by 27 percent as the formula required, and the $18 billion to pay for it will be taken from other health care programs. But the fix only lasts until the end of the year. On Jan. 1, doctors will face another big cut unless Congress again steps in.

23 Feb 2012

Actelion, Auxilium partner to develop and commercialize XIAFLEX

Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. announced today that they have entered into a long-term partnership for the development, supply and commercialization of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic for the potential treatment of Dupuytren's contracture and Peyronie's disease.

23 Feb 2012

Novel test identifies toxic foods which, when avoided, will help lose weight

Why did Oprah say, "I hope he can show me how to stop craving potato chips" during her Tony Robbins' segment this week? Does she really think that her potato chip binging and craving causes all of her weight fluctuations? Researchers at the University of Miami Miller School of Medicine may have the answer hidden in a novel laboratory test called a Bloodprint® and published this month in the Journal of Obesity and Weight Loss Therapy.

23 Feb 2012

Enrollment complete in Onyx Phase 3 ASPIRE trial for relapsed multiple myeloma

Onyx Pharmaceuticals, Inc. today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid) and low dose dexamethasone in patients with relapsed multiple myeloma.

23 Feb 2012

More toxic aldehydes found in reheated sunflower and linseed oil

Researchers from the University of the Basque Country (UPV/EHU, Spain) have been the first to discover the presence of certain aldehydes in food, which are believed to be related to some neurodegenerative diseases and some types of cancer. These toxic compounds can be found in some oils, such as sunflower oil, when heated at a suitable temperature for frying.

23 Feb 2012

Onyx reports total operating revenue of $237.0M for fourth quarter 2011

Onyx Pharmaceuticals, Inc. today reported its financial results for the full year and fourth quarter 2011. Onyx reported non-GAAP net income of $42.0 million, or $0.66 per diluted share, for the full year 2011 compared to non-GAAP net income of $39.2 million, or $0.63 per diluted share, for the same period in 2010.

23 Feb 2012

FDA approves Boston Scientific's ION and TAXUS Liberte paclitaxel-eluting stents

Boston Scientific Corporation's ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS Liberte Paclitaxel-Eluting Coronary Stent System have received U.S. Food and Drug Administration (FDA) approval for use in patients experiencing an acute myocardial infarction (AMI), or heart attack.

23 Feb 2012

AHA Heart-Check mark for almonds

The American Heart Association (AHA) recently certified almonds based on their nutrient profile to display the signature Heart-Check mark . The Heart-Check mark is overseen by AHA to help make it easier for shoppers to identify and choose heart-healthy foods.

23 Feb 2012